Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of Cordis.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Cordis
Australia Flag
Country
Country
Australia
Address
Address
Level 14/3 Parramatta Square 154 Macquarie Street, Parramatta NSW, 2150
Telephone
Telephone
(+61) 1800 077 421
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

By acquiring MedAlliance, Cordis has the potential to serve two million patients globally by 2027 with the SELUTION SLR™ (Sustained Sirolimus Release) drug-eluting balloon for the treatment of coronary artery disease.


Lead Product(s): Sirolimus

Therapeutic Area: Cardiology/Vascular Diseases Product Name: Selution SLR

Highest Development Status: ApprovedProduct Type: Small molecule

Recipient: MedAlliance

Deal Size: $1,135.0 million Upfront Cash: Undisclosed

Deal Type: Acquisition October 18, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY